2146/ ajhp1 10532 3. Antoniotti C, Borelli B, Rossini D et al (2020) AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer. BMC Can- cer 20:683.